These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7911121)

  • 1. Genetic polymorphisms of the non-obese diabetic (NOD) mouse.
    McClive PJ; Baxter AG; Morahan G
    Immunol Cell Biol; 1994 Apr; 72(2):137-42. PubMed ID: 7911121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of VH gene utilisation in the non-obese diabetic mouse.
    Leijon K; Freitas A; Holmberg D
    Autoimmunity; 1993; 15(1):11-8. PubMed ID: 8105987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure and function of CD72 in the non-obese diabetic (NOD) mouse.
    Rojas A; Xu F; Rojas M; Thomas JW
    Autoimmunity; 2003 Jun; 36(4):233-9. PubMed ID: 14563017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and physiological association of diabetes susceptibility with raised Na+/H+ exchange activity.
    Morahan G; McClive P; Huang D; Little P; Baxter A
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):5898-902. PubMed ID: 8016086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC-linked diabetogenic gene of the NOD mouse: molecular mapping of the 3' boundary of the diabetogenic region.
    Ikegami H; Kawaguchi Y; Ueda H; Fukuda M; Takakawa K; Fujioka Y; Fujisawa T; Uchida K; Ogihara T
    Biochem Biophys Res Commun; 1993 Apr; 192(2):677-82. PubMed ID: 8097912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of anti-Sm autoantibody production in NOD congenic mice narrowed to the Idd9.3 region.
    Irie J; Wu Y; Sass DA; Ridgway WM
    Immunogenetics; 2006 Feb; 58(1):9-14. PubMed ID: 16425035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased autoimmune diabetes in pIgR-deficient NOD mice is due to a "Hitchhiking" interval that refines the genetic effect of Idd5.4.
    Simpfendorfer KR; Strugnell RA; Brodnicki TC; Wijburg OL
    PLoS One; 2015; 10(4):e0121979. PubMed ID: 25835383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in adhesion markers, activation markers, and TcR in islet infiltrating vs. peripheral lymphocytes in the NOD mouse.
    Goldrath AW; Barber L; Chen KE; Alters SE
    J Autoimmun; 1995 Apr; 8(2):209-20. PubMed ID: 7612149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restriction fragment length polymorphisms in the major histocompatibility complex of the non-obese diabetic mouse.
    Lund T; Simpson E; Cooke A
    J Autoimmun; 1990 Jun; 3(3):289-98. PubMed ID: 1975742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterizations of candidate genes for IDD susceptibility from the diabetes-prone NOD mouse strain.
    Chesnut K; She JX; Cheng I; Muralidharan K; Wakeland EK
    Mamm Genome; 1993; 4(10):549-54. PubMed ID: 8268651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenic mice reveal genetic epistasis and overlapping disease loci for autoimmune diabetes and listeriosis.
    Wang N; Elso CM; Mackin L; Mannering SI; Strugnell RA; Wijburg OL; Brodnicki TC
    Immunogenetics; 2014 Aug; 66(7-8):501-6. PubMed ID: 24906421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of DNA polymorphisms between two inbred mouse strains--limitations of restriction fragment length polymorphisms (RFLPs).
    Knight AM; Dyson PJ
    Mol Cell Probes; 1990 Dec; 4(6):497-504. PubMed ID: 1982336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis for diabetes resistance in NOD/Wehi mice.
    Baxter AG; Hamilton F; Mandel TE; Augustine C; Cooke A; Morahan G
    Eur J Immunogenet; 1993 Oct; 20(5):409-17. PubMed ID: 9098409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine-1-phosphate reduces CD4+ T-cell activation in type 1 diabetes through regulation of hypoxia-inducible factor short isoform I.1 and CD69.
    Srinivasan S; Bolick DT; Lukashev D; Lappas C; Sitkovsky M; Lynch KR; Hedrick CC
    Diabetes; 2008 Feb; 57(2):484-93. PubMed ID: 18003758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with anti-CD6 and oral insulin immunization reverses recent onset diabetes in non obese diabetic mice but fails to induce lasting tolerance.
    Schneider DA; Sarikonda G; Montero E; von Herrath MG
    Clin Immunol; 2013 Dec; 149(3):440-1. PubMed ID: 24211845
    [No Abstract]   [Full Text] [Related]  

  • 16. Specific destruction of islet transplants in NOD<-->C57BL/6 and NOD<-->C3H/Tif embryo aggregation chimeras irrespective of allelic differences in beta-cell antigens.
    Leijon K; Hillörn V; Bergqvist I; Holmberg D
    J Autoimmun; 1995 Jun; 8(3):347-56. PubMed ID: 7575996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Non Obese Diabetic (NOD) mouse, as a model of T cell mediated autoimmune disease.
    Bach JF
    C R Acad Sci III; 1992; 314(9 Suppl):45-6. PubMed ID: 1422905
    [No Abstract]   [Full Text] [Related]  

  • 18. RFLP analysis of the MHC class III region defines unique haplotypes for the non-obese diabetic, cataract Shionogi and the non-obese non-diabetic mouse strains.
    Lund T; Shaikh S; Kendall E; Campbell RD; Hattori M; Makino S; Cooke A
    Diabetologia; 1993 Aug; 36(8):727-33. PubMed ID: 8104833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of QTLs that modify peripheral neuropathy in NOD.H2b-Pdcd1-/- mice.
    Jiang F; Yoshida T; Nakaki F; Terawaki S; Chikuma S; Kato Y; Okazaki IM; Honjo T; Okazaki T
    Int Immunol; 2009 May; 21(5):499-509. PubMed ID: 19261693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strain differences in allele and expression levels of CD72 on B-lymphocytes from NOD, AKR, NON and C57BL/6 mice.
    Wu J; Marler J; Lenchik NI; Gerling IC
    Immunol Lett; 2006 Mar; 103(2):115-20. PubMed ID: 16290205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.